ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • ACR Convergence 2026
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Home » Meeting Abstracts » ACR/ARHP Annual Meeting 2018

Abstract Number: 186

The Accuracy and Potential Impact of a Diagnostic Decision Support System in Rare Disease Cases

Simon Ronicke1,2, Martin C. Hirsch3, Ewelina Türk3, Katharina Larionov2, Daphne Tientcheu2 and Annette D. Wagner2, 1Ada Health GmbH, Belrin, Germany, 2Nephrology, Medical School Hannover, Hannover, Germany, 3Ada Health GmbH, Berlin, Germany

Share on X (Twitter) Share on Facebook Share on LinkedIn Share on Email
Print

Meeting: ACR/ARHP Annual Meeting 2018

Keywords: diagnosis, differential diagnosis, digital technologies, Education, medical and educational research

Session Information

Date: Sunday, October 21, 2018

Title: Education Poster

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Diagnosis in rare diseases cases is often delayed by several years. Main factors for delayed diagnosis are believed to be lack of awareness and knowledge about rare diseases among health care professionals. Diagnostic decision support systems (DDSS) have the potential to enhance clinical diagnosis by assessing case data based on incorporated medical knowledge and by suggesting relevant differential diagnoses. DDSS can contribute to professional support and education by visualising medical information and reasoning. We report about the use of Ada/DX, a DDSS in development, in an outpatient clinic for rare inflammatory systemic diseases. Presenting preliminary results, we evaluate the system’s diagnostic accuracy and assess the potential impact of this diagnostic and educational tool on the time to diagnosis.

Methods: This retrospective study is being conducted at the outpatient clinic for rare inflammatory systemic diseases at the Hannover Medical School, Germany. Ethical approval was obtained from the local ethics committee. To date, 82 (of a total 120) patient cases with confirmed diagnosis were included. The time of the visit of first documented symptoms and the time of diagnosis were identified. Time to diagnosis (TD) was calculated. Documented clinical evidence from the medical record was transferred to the DDSS and the disease suggestions in the DDSS were evaluated. Primary endpoint was the correctness of top disease suggestions for the visit of diagnosis. In these cases, secondary endpoints were the time to first correct top rare disease suggestion (T1R) and the time to first correct top 5 rare disease suggestion (T5R). The difference between TD and T1R and the difference between TD and T5R was calculated. Wilcoxon signed-rank test was conducted.

Results: On preliminary evaluation, primary accuracy of top suggestions of the DDSS at the time of diagnosis was 80.5% (71.9% to 89.1%, 95% CI). The table shows a comparison of the original time to diagnosis without the use of the DDSS and the time to correct disease suggestions with the use of the DDSS. (All times are expressed in months.)

Mean Std Dev PCTL 25 PCTL 50 PCTL 75
Among all cases
Time to diagnosis (TD) in medical record 57.8 84.2 2.3 18.0 74.5
Among cases with correct top suggestion at time of diagnosis
Time to correct top rare disease suggestion (T1R) 25.0 50.6 0.0 3.0 21.0
Time to correct top 5 rare disease suggestion (T5R) 13.1 31.9 0.0 0.0 5.3
Time difference (TD – T1R) 29.6 70.5 0.0 1.0 19.3
Time difference (TD – T5R) 41.5 78.3 0.8 9.5 40.0

The Wilcoxon signed-rank test shows a significant difference for TD – T1R (z-score -5.37, α=0.05, p<0.001) and TD – T5R (z-score -6.03, α=0.05, p<0.001). Main reasons for incorrect DDSS disease suggestions were multi-morbidity (cases with multiple relevant diagnoses), atypical disease presentation and high level of case complexity.

Conclusion: The DDSS suggested the correct diseases based on information from the medical record in most of the analysed rare disease cases. The DDSS often suggested the correct diseases at times prior to the visit of diagnosis. DDSS could be used as educational tools that suggest relevant differential diagnoses in rare disease cases. They might help to reduce time to diagnosis and improve patient outcomes. Prospective research is needed to verify the results.


Disclosure: S. Ronicke, Ada Health GmbH, 3; M. C. Hirsch, Ada Health GmbH, 4; E. Türk, Ada Health GmbH, 3; K. Larionov, None; D. Tientcheu, None; A. D. Wagner, None.

To cite this abstract in AMA style:

Ronicke S, Hirsch MC, Türk E, Larionov K, Tientcheu D, Wagner AD. The Accuracy and Potential Impact of a Diagnostic Decision Support System in Rare Disease Cases [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/the-accuracy-and-potential-impact-of-a-diagnostic-decision-support-system-in-rare-disease-cases/. Accessed .

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-accuracy-and-potential-impact-of-a-diagnostic-decision-support-system-in-rare-disease-cases/

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology